The MAPK/ERK signaling pathway is another critical target for inhibitors. This pathway is associated with regulating cell differentiation, survival, and development. Inhibitors targeting MAPK/ERK are used in cancer therapies to protect against unchecked cell proliferation and tumor growth. JAK/STAT signaling inhibitors regulate immune reactions and